Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$695M |
| 2 |
RTX Corp
RTX
|
+$549M |
| 3 |
Elevance Health
ELV
|
+$458M |
| 4 |
TransUnion
TRU
|
+$364M |
| 5 |
AbbVie
ABBV
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.08B |
| 2 |
HES
Hess
HES
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$502M |
| 4 |
Microsoft
MSFT
|
+$405M |
| 5 |
Danaher
DHR
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.44% |
| 2 | Financials | 18.84% |
| 3 | Healthcare | 13.07% |
| 4 | Industrials | 12.94% |
| 5 | Communication Services | 7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Progressive
PGR
$122B
| $2.38B | 0.77% |
14,935,652
+520,742
| +4% | +$81.5M |
|
27
Willis Towers Watson
WTW
$31.7B
| $2.33B | 0.75% |
9,670,510
-276,295
| -3% | -$63.9M |
|
28
McKesson
MCK
$96.8B
| $2.33B | 0.75% |
5,024,612
-124,182
| -2% | -$56.5M |
|
|
MRSH
29
Marsh
MRSH
$92B
| $2.29B | 0.74% |
12,110,217
-249,516
| -2% | -$48.2M |
|
30
Chubb
CB
$134B
| $2.28B | 0.74% |
10,102,563
-1,132,106
| -10% | -$248M |
|
|
31
Thermo Fisher Scientific
TMO
$213B
| $2.22B | 0.72% |
4,180,285
-2,226,776
| -35% | -$1.08B |
|
32
Prologis
PLD
$135B
| $2.19B | 0.71% |
16,435,675
-83,649
| -0.5% | -$9.5M |
|
|
SCHW
33
Charles Schwab
SCHW
$184B
| $2.13B | 0.69% |
30,994,967
+1,219,015
| +4% | +$70.4M |
|
34
Canadian National Railway
CNI
$76.1B
| $2.09B | 0.68% |
16,644,360
-192,235
| -1% | -$21.8M |
|
35
NXP Semiconductors
NXPI
$56.5B
| $2.02B | 0.65% |
8,781,206
-357,578
| -4% | -$72M |
|
36
Goldman Sachs
GS
$303B
| $2B | 0.65% |
5,195,203
+27,524
| +0.5% | +$9.19M |
|
37
Pfizer
PFE
$143B
| $1.97B | 0.64% |
68,506,441
+8,298,920
| +14% | +$251M |
|
38
American Express
AXP
$233B
| $1.97B | 0.64% |
10,502,519
-767,251
| -7% | -$124M |
|
39
KLA
KLAC
$239B
| $1.95B | 0.63% |
33,548,930
+61,640
| +0.2% | +$3.21M |
|
40
General Dynamics
GD
$103B
| $1.93B | 0.62% |
7,417,488
-386,398
| -5% | -$94.3M |
|
41
Morgan Stanley
MS
$332B
| $1.88B | 0.61% |
20,197,232
+575,114
| +3% | +$46M |
|
42
Eli Lilly
LLY
$1,000B
| $1.87B | 0.6% |
3,213,357
-97,502
| -3% | -$56.9M |
|
43
Northrop Grumman
NOC
$77.9B
| $1.86B | 0.6% |
3,965,139
-133,699
| -3% | -$62.7M |
|
44
Agilent Technologies
A
$39.5B
| $1.84B | 0.59% |
13,246,489
+2,170,219
| +20% | +$258M |
|
45
Duke Energy
DUK
$96.9B
| $1.81B | 0.59% |
18,699,484
-584,412
| -3% | -$53.2M |
|
46
Southern Company
SO
$107B
| $1.78B | 0.58% |
25,419,616
-684,281
| -3% | -$47M |
|
47
Lowe's Companies
LOW
$119B
| $1.77B | 0.57% |
7,968,132
-84,459
| -1% | -$17.1M |
|
48
Vulcan Materials
VMC
$36.7B
| $1.73B | 0.56% |
7,640,884
-103,259
| -1% | -$21.9M |
|
49
DuPont de Nemours
DD
$19.1B
| $1.7B | 0.55% |
17,650,634
-561,094
| -3% | -$51M |
|
50
Verisk Analytics
VRSK
$25.1B
| $1.64B | 0.53% |
6,859,562
-663,629
| -9% | -$157M |
|
Similar funds
Massachusetts Financial Services's Q4 2023 Portfolio in Review
As of Q4 2023, Massachusetts Financial Services held 885 positions worth $310B, up 8.4% from $286B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Massachusetts Financial Services's Q4 2023 filing shows 49 new, 322 increased, 455 reduced and 51 closed positions. Its largest new stake was Elevance Health: 990,628 shares worth $467M. The largest sale was Thermo Fisher Scientific, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Massachusetts Financial Services's largest Q4 2023 buy was Elevance Health: 990,628 shares worth $467M.
- Massachusetts Financial Services added most to Chevron in Q4 2023, an estimated $695M increase.
- Massachusetts Financial Services's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $1.08B.
- Massachusetts Financial Services fully exited Caterpillar in Q4 2023, selling an estimated $146M.
- Massachusetts Financial Services's ten largest holdings make up 19% of its $310B portfolio in Q4 2023.
- Massachusetts Financial Services opened 49 new positions and closed 51 in Q4 2023.
- Massachusetts Financial Services's portfolio value rose 8.4% quarter-over-quarter to $310B.
Based on Massachusetts Financial Services's 13F filing for Q4 2023, filed 8 Feb 2024.